Texas Congressman Drafts Bill to Keep Lab Test Oversight out of 'FDA's Lap,' Expand Authority of CMS | GenomeWeb

This article was updated on Oct. 17 to note that Rep. Burgess has introduced the bill and to indicate that the legislation has support from two large laboratories. Originally published Oct. 14.

By Turna Ray

Legislation seeking to keep regulation of laboratory-developed tests under the purview of the Centers for Medicare & Medicaid Services is taking shape under the leadership of Texas Congressman Michael Burgess and so far has the support of certain laboratory industry stakeholders.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.